Signify Health Inc Revenue per Employee (SGFY), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Signify Health Inc   (NYSE: SGFY)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare
 

Signify Health Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 11.91% in the fourth quarter 2022, year on year to cumulative value of $806 million, Signify Health Inc 's revenue per employee grew on a trailing twelve months basis to $ 151,981. The productivity of Signify Health Inc 's employees was 0.0%, above the company average.
Within the Healthcare sector Employees of 214 other companies have achieved higher revenue per employee. While Signify Health Inc 's total ranking has deteriorated compared to the previous quarter from 0 to 2297. Signify Health Inc has 5,300 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

SGFY Revenue per Employee (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter
Y / Y Revenue Change 11.91 % -29.82 % 15.7 % 20.28 % -6.25 %
Sales per Employee (TTM) $ 151,981 147,906 159,113 152,811 145,925
SGFY's Total Ranking # 2297 # 0 # 0 # 0 # 0
Seq. Revenue Change 45.21 % -43.22 % 13.72 % 19.35 % -8.94 %

SGFY Company Profile >> Back to SGFY Efficiency Comparisons >> Compare SGFY Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Healthcare Facilities Industry # 17
Healthcare Sector # 215
Overall Market # 2297

Revenue per Employee Statistics
High Average Low
$ 159,113 $ 151,547 $ 145,925
(Jun 30 2022)   (Dec 31 2021)



Financial Statements
Signify Health Inc 's Revenue MRQ $ 203 Millions Visit SGFY's Income Statement
Signify Health Inc 's Revenues TTM $ 806 Millions Visit SGFY's aggregate revenue growth
What are SGFY's Sales? Visit SGFY's Sales by Segment




Other Ratios
Signify Health Inc 's Income per Employee
Employees in Healthcare Facilities
Healthcare Facilities Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
SGFY's Revenue per Employee versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for SGFY's Competitors
Revenue per Employee for SGFY's Suppliers
Revenue per Employee for SGFY's Customers

You may also want to know
SGFY's Sales Growth Rates SGFY's Pe Price to earnings ratio SGFY's Receivables Turnover Ratio SGFY's Stock Quote
SGFY's Net Income Growth Rates SGFY's Ps Price to Sales ratio SGFY's Sales per Employee SGFY's Asset Turnover Ratio
SGFY's Net Margin SGFY's Pb Price to Book ratio SGFY's Financial Strength Ratios SGFY's Dividend Payout Ratio
Date modified: 2026-09-08T15:10:54+00:00




Companies with similar Revenue per Employee for 12 months ending Dec 31 2022, within Healthcare Sector Revenue per Employee Revenue 12 months ending Dec 31 2022Number of Employees Dec 31 2022
Ultragenyx Pharmaceutical Inc   265,010.21 $ 363.329  Million 1,371 
Pacific Biosciences Of California Inc   264,544.33 $ 128.304  Million 485 
Dexcom Inc   262,144.14 $ 2,909.800  Million 11,100 
Surmodics Inc   261,904.88 $ 101.881  Million 389 
Mersana Therapeutics inc   260,598.04 $ 26.581  Million 102 
Amneal Pharmaceuticals Inc   258,737.53 $ 2,199.269  Million 8,500 
Glaukos Corp  258,557.59 $ 282.862  Million 1,094 
Atrion Corporation  257,733.15 $ 183.506  Million 712 
Intercure Ltd   257,668.62 $ 115.951  Million 450 
Eargo Inc   256,882.76 $ 37.248  Million 145 
Esperion Therapeutics Inc   256,717.69 $ 75.475  Million 294 
Jaguar Health Inc   254,382.98 $ 11.956  Million 47 
Immucell Corporation  254,355.64 $ 18.568  Million 73 
Greenbrook Tms Inc   254,060.46 $ 69.104  Million 272 
Becton Dickinson And Company  252,777.78 $ 18,200.000  Million 72,000 
Amphastar Pharmaceuticals Inc   252,523.79 $ 498.987  Million 1,976 
Ensysce Biosciences Inc   252,338.30 $ 2.523  Million 10 
Standard Biotools Inc   251,794.34 $ 97.948  Million 389 
Myriad Genetics Inc   251,259.26 $ 678.400  Million 2,700 
Champions Oncology Inc   250,822.43 $ 53.676  Million 214 
Personalis Inc   250,180.77 $ 65.047  Million 260 
Psychemedics Corporation  249,900.99 $ 25.240  Million 101 
Bolt Biotherapeutics Inc   249,086.96 $ 5.729  Million 23 
Revance Therapeutics Inc   248,249.06 $ 132.565  Million 534 
Fresh Tracks Therapeutics Inc   247,964.29 $ 6.943  Million 28 
International Stem Cell Corporation  247,878.79 $ 8.180  Million 33 
Lemaitre Vascular Inc   246,795.42 $ 161.651  Million 655 
Atricure Inc   244,725.19 $ 330.379  Million 1,350 
Strata Critical Medical Inc   243,128.12 $ 146.120  Million 601 
Precision Optics Corporation Inc   243,061.01 $ 20.417  Million 84 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.